Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Molecular Characterization of Bone Marrow and Peripheral Blood Compartments from Patients with Plasma Cell Leukemia in the Mmrf Commpass Study

Sheri Skerget, PhD, Austin Christofferson, BSc, Sara Nasser, PhD, Christophe Legendre, PhD, The MMRF CoMMpass Network, Jennifer Yesil, Daniel Auclair, Sagar Lonial, Jonathan J Keats, PhD

Blood (2019) 134 (Supplement_1): 1782.

https://doi.org/10.1182/blood-2019-130697

Published: 2019

Journal Articles

Acute Healthcare Utilization and Predictors of Admission for Sickle Cell Disease in Illinois

Christina M Barriteau, MD, Mariam Kayle, PhD RN, Joseph M Feinglass, PhD, Paige VonAchen, BA, Robert I Liem, MD MS, Sherif M. Badawy, MD, Kristin Kan, MDMPH,MSc

Blood (2019) 134 (Supplement_1): 2107.

https://doi.org/10.1182/blood-2019-128150

Published: 2019

Journal Articles

Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Data from a Nationwide Belgian Registry

Blood (2019) 134 (Supplement_1): 4161.

https://doi.org/10.1182/blood-2019-127923

Published: 2019

Journal Articles

No Influence of Peripheral Blood CD34+ and CD3+ Graft Cell Counts on Outcomes after Reduced-Intensity Conditioning Transplantation Using Post-Transplant Cyclophosphamide

Alice Garnier, MD, Thierry Guillaume, MD PhD, Pierre Peterlin, Amandine Le Bourgeois, PhD, Alix Duquesne, Marion Eveillard, PharmD, PhD, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, MD, Cyrille Touzeau, MD PhD, Thomas Gastinne, MD, Anne Lok, MD, Antoine Bonnet, MD, Steven LE Gouill, MD PhD, Philippe Moreau, Marie C Bene, PharmSci, PhD, Patrice Chevallier, MD

Blood (2018) 132 (Supplement 1): 4577.

https://doi.org/10.1182/blood-2018-99-112453

Published: 2018

Journal Articles

Effect of Continuous Lenalidomide Treatment on Copy Number Alteration and Cytogenetic Abnormalities in Multiple Myeloma Cells

Paola Storti, PhD, Marina Bolzoni, PhD, Francesca Novara, PhD, Giannalisa Todaro, PhD, Valentina Marchica, Federica Costa, PhD, Tania Maldacena, PhD, Laura Notarfranchi, MD, Fabrizio Accardi, MD, Orsetta Zuffardi, PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD, Gabriella Sammarelli, PhD

Blood (2017) 130 (Supplement 1): 3039.

https://doi.org/10.1182/blood.V130.Suppl_1.3039.3039

Published: 2017

Journal Articles

Title: A Phase I Study with an Expansion Cohort of the Combination of Ipilimumab and Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4412 Arms D and E)

Catherine S. Diefenbach, MD, Fangxin Hong, PhD, Kevin A David, MD, Jonathon Cohen, Michael Robertson, MD, Ranjana Advani, MD, Neil D. Palmisiano, MD, Richard F. Ambinder, MD PhD, Brad S Kahl, Stephen Ansell, MD PhD

Blood (2016) 128 (22): 1106.

https://doi.org/10.1182/blood.V128.22.1106.1106

Published: 2016

Journal Articles

Preliminary Safety and Efficacy of the Combination of Brentuximab Vedotin and Ipilimumab in Relapsed/Refractory Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4412)

Catherine S. Diefenbach, MD, Fangxin Hong, PhD, Jonathon B. Cohen, MD, Michael J. Robertson, MD, Richard F. Ambinder, MD PhD, Timothy S. Fenske, MD, Ranjana H Advani, MD, Brad S Kahl, MD, Stephen Ansell, MD PhD

Blood (2015) 126 (23): 585.

https://doi.org/10.1182/blood.V126.23.585.585

Published: 2015

Journal Articles

Secondary Hemophagocytic Syndrome

Vinicius R. P. Mattos, MD, Michelle P. Silveira, MD, Flávia M. Ferreira, MD, Dirceu H. C. Campelo, MD, Juliano Cordova Vargas, MD, Clarissa L.M. Souza, MD, Nelson Hamerschlak, MD PhD, Fabio P S Santos, MD, Paulo A. A. Silveira, MD PhD

Blood (2014) 124 (21): 4958.

https://doi.org/10.1182/blood.V124.21.4958.4958

Published: 2014

Journal Articles

A Systematic Review On The Use Of Pharmacological Agents In Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Mansoor Radwi, MD, Arjuna Ponnampalam, MD, Marie E Faughnan, MD, Nadine Shehata, MD, MSC

Blood (2013) 122 (21): 4745.

https://doi.org/10.1182/blood.V122.21.4745.4745

Published: 2013

Journal Articles

Serum Alkaline Phosphatase Level On Day 4 Of G-CSF Administration Could Be a Simple Yet Practical Surrogate Marker For CD34 Mobilization and Collection

Yousef Zakharia, MD, Vamsi Kota, M.B;B.S, Joshua Mansour, MD, Radhika Prabhakar, MD, Ling Lan, MD. PHD, Farrukh T Awan, MD, Anand Jillella, MD

Blood (2013) 122 (21): 4519.

https://doi.org/10.1182/blood.V122.21.4519.4519

Published: 2013

Journal Articles

Design and Application of a Novel PNA Probe for the Detection At Single Cell Level of JAK2 V617F Mutation

Daniela Cilloni, MD, Valentina Rosso, PhD, Davide Torti, MD, Francesca Carnuccio, PhD, Anna Serra, PhD, Paolo Nicoli, MD, Valentina Gaidano, MD, Valentina Campia, PhD, Elisabetta Signorino, PhD, Chiara Calabrese, PhD, Sonia Carturan, PhD, Alessandra Favole, PhD, Giuseppe Saglio, MD, Francesco Frassoni, Enrico Bracco, PhD

Blood (2012) 120 (21): 1761.

https://doi.org/10.1182/blood.V120.21.1761.1761

Published: 2012

Journal Articles

Updated Interim Results of the Safety and Efficacy of Different Lenalidomide Starting Dose Regimens in Patients with Relapsed or Refractory (rel/ref) Chronic Lymphocytic Leukemia (CLL) (CC-5013-CLL-009 Study)

Clemens Wendtner, MD, Michael Hallek, MD, Graeme Fraser, Anne-Sophie Michallet, MD, PhD, Peter Hillmen, Jan Duerig, Stephanie A. Gregory, MD, Matt Kalaycio, MD, Stephan Stilgenbauer, MD, Andreas Buehler, Thomas J. Kipps, MD, PhD, Brendan Purse, Jennie Zhang, Jay Mei, MD, PhD, Asher Chanan-Khan, MD

Blood (2012) 120 (21): 3925.

https://doi.org/10.1182/blood.V120.21.3925.3925

Published: 2012

Journal Articles

Treatment of Consecutive Patients with Chronic Myeloid Leukemia In the Cooperating Centers From the Slovak Republic After 2000 – A Report From the Population Based CAMELIA Registry

Eva Demeckova, Martin Mistrik, MD, PhD, Ludmila Demitrovicova, Juraj Chudej, MD, Imrich Markuliak, Elena Tothova, Jan Muzik, MSci, PhD, Ladislav Dusek

Blood (2011) 118 (21): 4439.

https://doi.org/10.1182/blood.V118.21.4439.4439

Published: 2011

Journal Articles

The Efficacy and Safety of the Addition of Rituximab to CHOP or a CHOP-Like Regimen In First Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Meta-Analysis

Aaron T Gerds, MD, Laura C Michaelis, MD, Danielle Shafer, DO

Blood (2010) 116 (21): 4913.

https://doi.org/10.1182/blood.V116.21.4913.4913

Published: 2010

Journal Articles

The Diagnostic Value of CD1d Expression In Leukemic B-Chronic Lymphoproliferative Disorders (B-CLPDs)

Eleytherios Moustakidis, Emmanuil Spanoudakis, Irene Bouchliou, Evangelia Nakou, Paraskevi Miltiades, asiliki Kotoula, V, Dimitrios Margaritis, George Bourikas, Richard Szydlo, Anastasios Karadimitris, Konstantinos Tsatalas, MD, PhD, Ioannis Kotsianidis, MD, PhD

Blood (2010) 116 (21): 3576.

https://doi.org/10.1182/blood.V116.21.3576.3576

Published: 2010

Journal Articles

High Dose Chemotherapy and Autologous Stem Cell Transplantation in the Primary Therapy of Advanced Follicular Lymphoma in Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Murtadha K. Al-Khabori, BSc, MD, FRCPC, John de Almeida, Gordon Guyatt, John Kuruvilla, Michael Crump

Blood (2009) 114 (22): 2314.

https://doi.org/10.1182/blood.V114.22.2314.2314

Published: 2009

Journal Articles

Emergency Department Follow-up for Adults with Sickle Cell Disease.

Paula Tanabe, PhD, MPH, RN, John W Hafner, MD, MPH, Zoran Martinovich, PhD, Elena Zvirbulis, MS, Ted Wun, MD, Nicole Artz, MD

Blood (2009) 114 (22): 241.

https://doi.org/10.1182/blood.V114.22.241.241

Published: 2009

Journal Articles

Phase II Trial of the mTOR Inhibitor RAD001 in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: The Dana Farber Cancer Institute Experience.

Irene M. Ghobrial, M.D., Stacey Chuma, RN, Amy Sam, Renee Leduc, Marybeth Nelson, PA, Kelly O’Connor, Brianna Harris, Jacob Soumerai, Diane Warren, Eric Jacobsen, MD, Daniel DeAngelo, MD, PhD, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Thomas E. Witzig, MD, Steven P. Treon, MD, PhD

Blood (2008) 112 (11): 1011.

https://doi.org/10.1182/blood.V112.11.1011.1011

Published: 2008

Journal Articles

Nck Beta Adapter Protein Coordinates Bcr-Abl/Sam68 Intermolecular Interaction.

Enrico Bracco, PhD, Erika Deklic, Valentina Rosso, Stefano Mussino, PhD, Francesca Arruga, PhD, Sonia Carturan, PhD, Francesca Messa, PhD, Ilaria Defilippi, PhD, Cristina Panuzzo, PhD, Paolo Nicoli, Emanuela Messa, MD, Antonia Rotolo, Roberto Pedrola, Alessandro Morotti, MD, Alessandra Balbo, Ilaria Iacobucci, PhD, Giovanni Martinelli, Daniela Cilloni, Giuseppe Saglio

Blood (2008) 112 (11): 1093.

https://doi.org/10.1182/blood.V112.11.1093.1093

Published: 2008

Journal Articles

Confirmation of the Efficacy and Safety of Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory Diffuse Large-B-Cell Lymphoma: Results of An International Study (NHL-003)

Myron S. Czuczman, MD, Julie M. Vose, MD, Pier Luigi Zinzani, MD, Craig B. Reeder, MD, Rena Buckstein, MD, FRCPC, Corinne Haioun, Reda Bouabdallah, MD, Jonathan Polikoff, MD, Pingshan Guo, Annette Ervin-Haynes, Dennis Pietronigro, Jerome B. Zeldis, MD, Thomas E. Witzig

Blood (2008) 112 (11): 268.

https://doi.org/10.1182/blood.V112.11.268.268

Published: 2008

NARROW

Molecular Characterization of Bone Marrow and Peripheral Blood Compartments from Patients with Plasma Cell Leukemia in the Mmrf Commpass Study

Acute Healthcare Utilization and Predictors of Admission for Sickle Cell Disease in Illinois

Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Data from a Nationwide Belgian Registry

No Influence of Peripheral Blood CD34+ and CD3+ Graft Cell Counts on Outcomes after Reduced-Intensity Conditioning Transplantation Using Post-Transplant Cyclophosphamide

Effect of Continuous Lenalidomide Treatment on Copy Number Alteration and Cytogenetic Abnormalities in Multiple Myeloma Cells

Title: A Phase I Study with an Expansion Cohort of the Combination of Ipilimumab and Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4412 Arms D and E)

Preliminary Safety and Efficacy of the Combination of Brentuximab Vedotin and Ipilimumab in Relapsed/Refractory Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4412)

Secondary Hemophagocytic Syndrome

A Systematic Review On The Use Of Pharmacological Agents In Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Serum Alkaline Phosphatase Level On Day 4 Of G-CSF Administration Could Be a Simple Yet Practical Surrogate Marker For CD34 Mobilization and Collection

Design and Application of a Novel PNA Probe for the Detection At Single Cell Level of JAK2 V617F Mutation

Updated Interim Results of the Safety and Efficacy of Different Lenalidomide Starting Dose Regimens in Patients with Relapsed or Refractory (rel/ref) Chronic Lymphocytic Leukemia (CLL) (CC-5013-CLL-009 Study)

Treatment of Consecutive Patients with Chronic Myeloid Leukemia In the Cooperating Centers From the Slovak Republic After 2000 – A Report From the Population Based CAMELIA Registry

The Efficacy and Safety of the Addition of Rituximab to CHOP or a CHOP-Like Regimen In First Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Meta-Analysis

The Diagnostic Value of CD1d Expression In Leukemic B-Chronic Lymphoproliferative Disorders (B-CLPDs)

High Dose Chemotherapy and Autologous Stem Cell Transplantation in the Primary Therapy of Advanced Follicular Lymphoma in Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Emergency Department Follow-up for Adults with Sickle Cell Disease.

Phase II Trial of the mTOR Inhibitor RAD001 in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: The Dana Farber Cancer Institute Experience.

Nck Beta Adapter Protein Coordinates Bcr-Abl/Sam68 Intermolecular Interaction.

Confirmation of the Efficacy and Safety of Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory Diffuse Large-B-Cell Lymphoma: Results of An International Study (NHL-003)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only